The only hitherto known antibiotic originating from the genus Oidiodendron is fuscin, which has been isolated from a strain of Oidiodenron fitscum1). In this paper we shall report the isolation of anew antibiotic, PR-1350, from a number of strains of Oidiodendron truncatum.
Microorganisms
The antibiotic was first isolated from a strain of Oidiodendron truncatum (HL-972; CBC 475.78) isolated from a soil sample collected near Copenhagen and was subsequently shown to be produced by all of a number of strains of O. truncatum tested, whereas none of the examined strains of other Oidiodendron species produces any antibacterial activity (Table 1) . and an UV maximum was observed for both at 230 nm (Eicm 310). On the other hand, the optical rotations of freshly prepared solutions of the two compounds differ considerably. However, the optical of such solutions change in the course of some hours and, eventually, the two solutions show comparable rotations values (Table 2 ).
Physico-chemical Properties
An NMR spectrum of PR-1381 can be obtained when the spectrum is run immediately after preparation of the solution, and the best resolved spectrum is that obtained in DMSO-de (Fig. 3) . However, when the solution is left at room temperature the appearance of the spectrum changes during the next few hours. The end point of a similar transformation in CDCl, solution is shown in Fig. 4 together with the NMR spectrum of PR-1350 in CDCl3. The similarity of these two spectra is obvious, the The specific rotation of PR-1350 and PR-1381.
Not determined. (Table 3) .
No activity was observed against a number of fungi tested in the same way.
Given intraperitoneally to mice PR-1350 has an LD50 value of approximately 250 mg/kg with deaths occurring after about one week. The antibiotic has been tested in the P-388 lymphocytic leukemia screening model of the National Cancer Institute and has shown significant inhibition of the tumor at all doses tested (Table 4) . duct, designated PR-1383. In Table 5 the 13C NMR data for this compound are shown together with some simple deductions regarding the chemical nature of the carbon atoms. These data imply that the molecular formula of the compound is C20OH341O5 which is in accordance with the molecular peak seen at 354 in the field ionization mass spectrum. This formula leads to the assumption that the compound is derived from a diterpene. As two of the four double bond equivalents corresponding to the formula C20H34O, are occupied by a double bond and an epoxide (Table 5) , the diterpene in question must be of the bicarbocyclic type. Furthermore, the fragments in Table 5 I  II  I  I  III  III  III  I  I  I  I  I  I  I  I  I  I  I  IV  IV  IV  IV   Strain,   CJ  EC  E13  KA2  DA3  DB  IX3  HA  HC7  HE  HC8  HJ  HJ3  BA2  HG4  HT  HL2  MO  ZA  zz  ZM  70 MIC (ulg/ml)b Table 4 . Activity of PR-1350 against P-388 lymphocytic leukemia in the mouse (two experiments).a Table 5 .
If PR-1383 belongs to any of the five types of diterpenes represented by the formulas A -E in Charts 1 and 2, it should be possible to fit these labelled carbon atoms into the dotted positions in that skeleton.
Three of the candidates (A, D, and E) can easily be ruled out as they all contain two labelled quaternary positions, whereas the two quaternary carbon atoms in Table 5 (11 and 12) are both unlabelled. One of the remaining skeletons (C) does indeed contain two unlabelled quaternary positions, but has to be ruled out as it contains two labelled potential methyl groups and only one such group is found in Table 5 (5). This leaves only one candidate, the clerodane skeleton (B), and inspection of Table 5 reveals that the numbers of labelled potential CH-groups, CH-groups, CH-groups, and quaternary carbon atoms found in PR-1383 (and thus in PR-1350) are exactly the same as the numbers of the corresponding dotted positions in the clerodane skeleton.
Thus, biosynthetic considerations suggest that the antibiotic PR-1350 is a diterpene of the clerodane type. This is remarkable for two reasons: Firstly, PR-1350 is to our knowledge the only known clerodane derivative showing antimicrobial activity, and secondly, this seems to be the first example of a clerodane derivative isolated from a fungus. All hitherto reported compounds of this type have been isolated from higher plants.
The detailed structure determination of PR-1350 will be described in a forthcoming publication.
Experimental

General
The NMR spectra were obtained from 10°x; solutions (deuterated solvent UvasoleR) on a JEOL FX 100 spectrometer.
A 5 mm dual carbon/proton probe was normally used and a minimum of 16 or 2000 spectra were recorded in the case of proton and carbon, respectively.
A 70" 90° single pulse was used together with a pulse repetition time sufficient to allow full relaxation. In all cases, the digital resolution was kept better than the spectrometer resolution. UV data were obtained on a Beckmann ACTA CIII spectrometer, and optical rotations were measured on a Perkin Elmer 141 polarimeter. Infrared spectra were recorded on a Perkin Elmer PE 457 grating spectrometer in KBr.
All solvents used were analytical or spectrochemical grade. Sodium [1-"C]acetate used in the biosynthetic incorporation study was obtained from Stohler Isotope Chemicals cat. no. C80. Fermentation A well-grown agar slant of strain CBS 629.70 was used to inoculate eight 2,000-ml Erlenmeyer flasks, each containing 250 ml of a medium composed of 2 corn steep liquor, 5 % sucrose, 1% KH2-PO, • 2H2O and 0.05% MgSO4 • 7H2O9 the pH being adjusted to 7.2 before sterilization. The flasks were incubated at 20-22°C for 3 days on a reciprocating shaker, and the growth was then transferred to eight jar fermentors each containing 5 liters of the same medium, and stirred with aeration at 20°C for 48 hours.
These seed cultures were then used to inoculate 1,500 liters of a medium composed of 2°o malt extract, 2 % sucrose, 0.75 % soybean meal, 0.75 % meat and bone meal, 0.1 % K2HPO, and 0.2 % silicone (Baysilon EN-Bayer) (pH being adjusted to 6.0 prior to sterilization) in a 2,000-liters stainless steel tank fermentor operated at 2°C and 110 rpm with an aeration rate of 1,200 liters/minute, using silicone as an antifoaming agent. During the fermentation the pH was maintained at 6.0 by addition of phosphoric acid.
Samples were taken at intervals and the antibiotic activity determined by the agar cup method using Staphylococcus aureus as a test organism. Peak antibiotic potency was obtained after 4 days of incubation.
Isolation of PR-1350 Fermentation broth prepared as described above was filtered using kieselguhr as a filter aid. The filtrate (1,050 liters) was passed at a rate of 2 liters/minute through a column prepared from 4.4 liters of Diaion HP-20 (height: 56 cm, diameter: 10 cm; the resin was treated before use with water, 2 N aqueous sodium hydroxide, water, methanol, 2 N aqueous hydrogen chloride, water, methanol, and water). The column was washed with water (25 liters), 25 % aqueous methanol (12 liters), 50% aqueous methanol (12 liters), and 75% aqueous methanol (12 liters), and was then eluted with methanol, fractions of 2 liters being collected. Fractions 2 -7, which contained the majority of the antibacterial activity, were combined and evaporated in vacuo. The residue was extracted with 400 ml of methanol, and after filtration the methanol was evaporated. The residue was dissolved in methanol (50 ml), and ether (800 ml) was added to the stirred solution. The precipitate formed was filtered off and discarded, and the filtrate was concentrated in vacuo to an oil which was dissolved in methanol -water (95: 5, 100 ml) and submitted to column chromatography on 600 ml of Diaion HP-20 (height: 90 cm, diameter: 2.9 cm) by eluting with methanol -water (95: 5). The first 500 nil of eluent were discarded and then fractions containing each 25 ml were collected. Fractions 31 -103 containing about half of the activity (S. aureus as test organism) were combined and evaporated in vacuo to give 10.0 g of an oil.
This crude product was dissolved in methanol (20 ml) and applied to a column of Sephadex LH-20 (height: 90 cm, diameter: 2.9 cm), and the column was eluted with methanol. Active fractions (150 ml) were collected and evaporated to dryness in vacuo to yield an oil, which was dissolved in a mixture of ether (100 ml) and cyclohexane (200 ml). The solution was treated with 3 g of Norit, filtered, and evaporated in vacuo to a volume of 50 ml. 200 ml of cyclohexane was added with stirring, and the precipitate which formed was filtered off, washed with cyclohexane and dried to yield 6.0 g of PR-1350 as a colorless amorphous powder.
The optical rotation of the product is given in Table 2 , the IR spectrum is shown in Fig. 1 , and the 1H NMR spectrum is shown in Fig . 4B .
The UV spectrum of the compound dissolved in ethanol shows a maximum at 230 nm (E1%1cm 310).
Preparation
of the Crystalline Methanolate PR-1381 500 mg of amorphous PR-1350 was dissolved in 1.5 ml of methanol and the solution was left at 5°C. During 72 hours crystals slowly precipitated. 15 ml of diisopropyl ether was then added, and the crystals were collected by filtration, washed with diisopropyl ether, and dried to yield 300 mg of colorless crystalline methanolate of PR-1350, called PR-1381, nip. 139-141°C.
Anal. Calcd. for C21H32O6: C 66.29, H 8.48. Found: C 66.14, H 8.49. The optical rotation of the product is given in Table 2 , the IR spectrum is shown in Fig. 2 and the NMR spectrum of a freshly prepared solution in DMSO-d6 is shown in Fig. 3 .
The UV spectrum of the compound dissolved in ethanol shows a maximum at 230 (E,"'m 310).
Reduction of PR-1350 with Sodium Borohydride (PR-1383)
To a solution of PR-1350 (2 g) in ethanol (100 ml) was added at 0°C sodium borohydride (4 g), and the resulting solution was stirred at 0°C for 1.5 hours. Acetone (10 ml) was then added to destroy the remaining borohydride followed after 15 minutes by ethyl acetate (800 ml) and water (200 ml). The aqueous phase was extracted twice with 200 ml of ethyl acetate, and the combined organic phases were washed with saturated aqueous sodium chloride, dried over magnesium sulfate, and evaporated in vacuo to dryness. From the residue the main product was isolated by column chromatography on silica gel developed with acetone -hexane (1: 1) yielding in addition to a number of fractions in which the main product was contaminated with various by-products, 643 mg of the pure compound as a colorless oil. 13C NMR data for this product (PR-1383) are given in Table 5 . The antibiotic was isolated as described above to give 30 mg of amorphous material, which was reduced with sodium borohydride and purified by chromatography as described above yielding 8 mg of 13C-labelled PR-1383. The 13C NMR spectrum of this product showed that a total of eight carbon atoms were labelled with 13C as shown in detail in Table 5 .
